Allied Team

We selected Allied’s team from the very best across a diverse range of sectors: medicine, pharmaceuticals, cannabis R&D, Post Traumatic Stress Injury (PTSI), innovative production, product development, and sustainable business growth. Here are the Directors, Officers and Advisers working to make Allied the leading provider of targeted cannabinoid health solutions.

Calum Hughes

Founder, Chief Executive Officer

Calum has over 15 years in the medical field, including Cardiovascular and Cerebrovascular Rehabilitation. He worked as a Director of a 140-bed Acute Care Hospital and as an Adjunct Professor for the University of British Columbia in the areas of Health Economics, Health Evaluation, and Canadian Health Systems.

Calum has also been a QA Healthcare Consultant on large projects within the health sector for government organizations as well as the pharmaceutical industry. His clinical experience includes functioning as a health care provider for patients with chronic diseases, acute disability, and workplace health and wellness.

Calum is currently working towards his doctorate with Royal Roads University.

Jim Smeeding

Director, Vice President of Pharmaceutical Development

Jim Smeeding is a Registered Pharmacist (RPh) from the State University of New York, and also holds a Masters degree in Business Administration (MBA) from the University of Texas (with an emphasis in pharmaceutical marketing, organizational strategies and pharmaceutical sales management). He is the Executive Vice President of CP Pharmaceutical International: a division of CP Global Health (Hong Kong and Texas).

Some of Mr. Smeeding’s past experience has included working as the Executive Director of the National Association of Specialty Pharmacy (NASP), a founder of the Center for Pharmacoeconomic Studies at the University of Texas College of Pharmacy and a founder and President of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). Within Mr. Smeeding’s specialty pharmacy consultancy practice, Project Rx, Mr. Smeeding has offered management services to hospitals and pharmaceutical companies throughout the US.

Mr. Smeeding has also been active in other Cannabis Based Medicines (CBM) research as a founder of CannaPharma Rx and has authored more than 85 peer-reviewed publications and has given hundreds of presentations. Mr. Smeeding has worked with many major pharmaceutical companies and is one of the founding partners and president of Indication Biosciences; an early stage drug discovery company that is examining the use of CBD with statin agents to safely lower lipid anomalies. Mr. Smeeding also was the Executive VP and founder of Engaged Media; a technology driven patient engagement solution used in multiple pharmaceutical co-pay programs that was acquired in May of 2018.

Jim Bullock
Director, Chief Operating Officer

Born and raised in Kelowna, BC, Canada, Jim Bullock comes from one of Kelowna’s oldest pioneer families, which possesses a rich history in both agricultural innovation and entrepreneurial spirit.

Jim brings 10 years of experience to the Allied team from MMAR, MMPR, and ACMPR cannabis cultivation, genetics, compliance and facility design.

Previous to joining Allied, Jim owned and operated a company specializing in both personal and corporate finance for clients, which offered exportable services in overseas and offshore markets.

Earlier, Jim worked in the oil and gas industry specializing in offshore construction. Jim also owned and operated an agricultural management and consulting firm, which renovated and replanted over 2,500 acres of orchard and vineyard in the Okanagan Valley. He was also the Kelowna site operations manager for Kettle Mountain Ginseng, one of the pioneers in the British Columbia ginseng industry.

Ryan Maarschalk
Chief Financial Officer

We’re very excited to officially announce the appointment of Mr. Ryan Maarschalk, Bsc, CPA, as Allied’s new Chief Financial Officer. Mr. Maarschalk is a driven leader with a successful track record in driving growth for companies.

Some of Mr. Maarschalk’s past experience includes the merger and acquisition of IMPACT Radio Accessories to private equity for $23M, and building extraction and cultivation facilities in Las Vegas with 1933 industries.

Throughout his career, Mr. Maarschalk has worked across a variety of verticals as a consulting CFO, including micro-mobility, wineries, cannabis and real estate, and we are thrilled to welcome him to our team.

Dr. Terry Johnstone
Medical Advisor to the Board

Dr. Terry Johnstone is an Occupational Physician doing Occupational Medicals for Transport Canada Aviation & Marine, WorksafeBC Commercial Drive Medicals, as well as DCBC, OGUK off-shore Medicals, FAA class 1 examiner, and fitness to work and pre-placement medicals.

Dr. Johnstone is also active in Audiometry, Resting and Stress EKGs, NIOSH Drug testing, Chester fitness test, Farnsworth and Titmus visual screening, Visia Facial Skin assessment, and has 10 years of experience in Botox, fillers and skin rejuvenation.

Lindsey Donovan
Executive Assistant to the Board of Directors

Lindsey Donovan has 20 years of experience as an entrepreneur and business builder.

Her professional work as a commercial and corporate photographer has involved working with heads of state, presidents and premiers, CEOs and highly influential individuals, as well as contributing to marketing campaigns related to public relations and corporate reporting.

Lindsey has traveled extensively across four continents, has lived in Canada and the US, and received her technical education at Focal Point Visual Arts Learning Centre.

Sign up to our newsletter and get first access to the latest investor news, events, and other important information related to Allied Health.

Keep Informed